Susumu Kawate

Amplification of c-<i>myc</i> in Hepatocellular Carcinoma: Correlation with Clinicopathologic Features, Proliferative Activity and p53 Overexpression

Susumu Kawate, Toshio Fukusato, S Ohwada et al. · Oncology · 1999 · 142 citations

Medicine, Oncology, Pathology +16

Low-Dose Erythromycin Reduces Delayed Gastric Emptying and Improves Gastric Motility After Billroth I Pylorus-Preserving Pancreaticoduodenectomy

Susumu Ohwada, Yoshihiro Satoh, Susumu Kawate et al. · Annals of Surgery · 2001 · 122 citations · Full text

Medicine, Pharmacotherapy, Surgery +11

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study

Susumu Ohwada, T Ikeya, Tadahiro Yokomori et al. · British Journal of Cancer · 2004 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma

Susumu Ohwada, Susumu Kawate, Kenta Hamada et al. · British journal of surgery · 2006 · 84 citations · Full text

Medicine, Perioperative Medicine, Surgery +16

Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma.

Susumu Kawate, Seiichi Takenoshita, Susumu Ohwada et al. · International Journal of Oncology · 1999 · 54 citations

Medicine, Genetics, Molecular Genetics +14